← back to search

Claudia Giesecke‐Thiel

Max Planck Institute for Molecular Genetics · DE
Area of research
Immunology · Infectious Diseases
Research interest
Research interests include Immunotherapy and Immune Responses, T-cell and B-cell Immunology, SARS-CoV-2 and COVID-19 Research, and Immune Cell Function and Interaction.
h-index
21
citations
4,194
works
50
NIH funding
primary concept
Biology
email

Recent publications

CD8 <sup>+</sup> T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells
Science Advances 2025cited by 2position: middledoi
Aging and Viral Evolution Impair Immunity Against Dominant Pan‐Coronavirus‐Reactive T Cell Epitope
European Journal of Immunology 2025cited by 1position: middledoi
Odd skipped-related 1 controls the pro-regenerative response of fibro-adipogenic progenitors
npj Regenerative Medicine 2023cited by 27position: middledoi
Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
Frontiers in Immunology 2023cited by 8position: middledoi
SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod
Journal of Neurology Neurosurgery & Psychiatry 2022cited by 31position: lastdoi
Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly
The Journal of Immunology 2022cited by 23position: middledoi
Cross-reactive CD4 <sup>+</sup> T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
Science 2021cited by 312position: lastdoi
Generation of HBsAg‐reactive T‐ and B‐cells following HBV vaccination in serological non‐responders under hemodialysis treatment
European Journal of Immunology 2021cited by 6position: middledoi
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Nature 2020cited by 1,395position: middledoi
Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium
Nature Communications 2019cited by 98position: middledoi
High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire
Nature Biotechnology 2013cited by 428position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Manuela Dingeldey · Berlin-Brandenburger Centrum für Regenerative Therapien4 papers (2022–2025)Julian Braun · Humboldt-Universität zu Berlin4 papers (2022–2025)Larissa Henze · Berlin Institute of Health at Charité - Universitätsmedizin Berlin4 papers (2022–2025)Beate Kruse · Berlin Institute of Health at Charité - Universitätsmedizin Berlin4 papers (2022–2025)Lucie Loyal · Siemens (Hungary)4 papers (2022–2025)Andreas Thiel · Martin Luther University Halle-Wittenberg4 papers (2022–2025)Lil Meyer‐Arndt · Max Delbrück Center4 papers (2022–2025)Norbert Mages · Max Planck Institute for Molecular Genetics3 papers (2019–2025)Ulf Reimer · JPT Peptide Technologies (Germany)3 papers (2022–2025)Andreas Nitsche · Zuse Institute Berlin3 papers (2022–2025)Maike Mangold · Berlin Institute of Health at Charité - Universitätsmedizin Berlin3 papers (2022–2025)Karsten Jürchott · Charité - Universitätsmedizin Berlin3 papers (2022–2025)Bernd Timmermann · Max Planck Institute for the Study of Societies3 papers (2023–2025)Holger Wenschuh · JPT Peptide Technologies (Germany)2 papers (2023–2025)Florian Klein · Chirurgische Universitätsklinik Heidelberg2 papers (2022–2023) · 2 papers (2022–2023) · 2 papers (2023–2025) · 2 papers (2023–2025)Birgit Sawitzki · Universidad Bernardo O'Higgins2 papers (2022–2025)Leif Erik Sander · Charité - Universitätsmedizin Berlin2 papers (2022–2022)